Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#66N0D)
This report describes a recent finding that mpox incidence among unvaccinated men aged 18-49 years was 10 times as high as vaccinated men who received both JYNNEOS doses.